Faith Wagner
Nurse Practitioner · Bismarck, NDNPI 1346281870
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations.
Across 95 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$214
- AstraZeneca$142
- Novo Nordisk$139
- Dexcom, Inc.$126
- Novartis$120
- Travere Therapeutics, Inc.$108
- plus $804 from 20 others
What the payments were for
- Food & beverage$1,653100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 13 | $214 |
| AstraZeneca(2 entities) | 9 | $142 |
| Novo Nordisk | 9 | $139 |
| Dexcom, Inc. | 7 | $126 |
| Novartis | 6 | $120 |
| Travere Therapeutics, Inc. | 6 | $108 |
| Boehringer Ingelheim | 7 | $106 |
| Lilly USA, LLC | 6 | $97 |
| Mallinckrodt Hospital Products Inc. | 4 | $81 |
| Calliditas Therapeutics US Inc. | 4 | $74 |
| Medtronic | 1 | $70 |
| Abbott | 3 | $53 |
| Ardelyx, Inc. | 2 | $39 |
| Sanofi | 2 | $39 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Exact Sciences | 2 | $29 |
| AbbVie | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Vifor Pharma, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Pfizer | 1 | $15 |
| Bayer | 1 | $14 |
| Lexicon Pharmaceuticals, Inc. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
| Axsome Therapeutics, Inc. | 1 | $11 |
How this compares
$1,653 in reported general payments places this provider in the 85th percentile of 455 nurse practitioner providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 216 | $33,421 |
| RenvelaSevelamer Carbonate | 15 | $22,651 |
| Calcium Acetate | 126 | $6,605 |
| Midodrine Hcl | 137 | $2,368 |
| Bumetanide | 25 | $993 |
| Carvedilol | 42 | $424 |
| Clonidine Hcl | 12 | $408 |
| Amlodipine Besylate | 40 | $363 |
| Omeprazole | 14 | $259 |
| Losartan Potassium | 43 | $244 |
| Hydralazine Hcl | 21 | $174 |
| Furosemide | 15 | $171 |
| Famotidine | 19 | $169 |
| Lactulose | 13 | $166 |
| Metoprolol Succinate | 15 | $150 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Bismarck
- Lisa ClairmontBismarck$15K
- McKinzie NussBismarck$7K
- Paula MochBismarck$5K
- Trina KaiserBismarck$5K
- Cassie HoltBismarck$5K
- Katherine CarvellBismarck$5K
- Shih Ru MartinBismarck$5K
- Janel OlsonBismarck$4K
- Mallorie EmoryBismarck$3K
- Kayla CoferBismarck$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.